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Human uterine lymphocytes 
acquire a more experienced and 
tolerogenic phenotype during 
pregnancy
Dorien Feyaerts1, Marilen Benner1, Bram van Cranenbroek1, Olivier W. H. van der Heijden2, 
Irma Joosten1 & Renate G. van der Molen1
Pregnancy requires a delicate immune balance that nurtures the allogeneic fetus, while maintaining 
reactivity against pathogens. Despite increasing knowledge, data is lacking on the transition of pre-
pregnancy endometrial lymphocytes to a pregnancy state. Here, we immunophenotyped lymphocytes 
from endometrium (MMC), term decidua parietalis (DPMC), and PBMC for direct comparison. We found 
that the immune cell composition of MMC and DPMC clearly differ from each other, with less NK-cells, 
and more NKT-cells and T-cells in DPMC. An increased percentage of central memory and effector 
memory T-cells, and less naive T-cells in DPMC indicates that decidual T-cells are more experienced 
than endometrial T-cells. The increased percentage of CD4+CD25highCD127− Treg in DPMC, including 
differentiated Treg, is indicative of a more experienced and tolerogenic environment during pregnancy. 
The Th cell composition of both MMC and DPMC was different from PBMC, with a preference for Th1 
over Th2 in the uterine environment. Between MMC and DPMC, percentages of Th cell subsets did not 
differ significantly. Our results suggest that already before pregnancy a tightly controlled Th1/Th2/
Th17 balance is present. These findings create opportunities to further investigate the underlying 
immune mechanism of pregnancy complications using menstrual blood as a source for endometrial 
lymphocytes.
Pregnancy requires a complex interplay of immune cells. Maternal lymphocytes need to accommodate the 
semi-allogeneic fetus and still maintain robust immune reactivity against pathogens. The barrier between the 
semi-allogeneic fetus and the maternal immune system is the placenta. At this fetal-maternal interface, maternal 
lymphocytes of the decidua come into close contact with cells of fetal origin, i.e. trophoblast cells. This con-
tact occurs at two different sites, between invading trophoblast cells and the decidua basalis, which is the site 
of implantation, and chorionic trophoblast cells and the decidua parietalis, which are part of the membranes 
surrounding the fetus1. These trophoblast cells have restricted HLA expression (HLA-C, HLA-E, and HLA-G). 
Direct response to fetal allogeneic HLA is primarily via HLA-C, but also indirect presentation of fetal antigens by 
maternal APCs can elicit an anti-fetal maternal leukocyte response2–6. This restricted immune recognition makes 
that the uterine immune cell composition and phenotype is different from other mucosal sites1.
Each month, during the menstrual cycle, the uterus prepares itself for pregnancy by a large influx of leukocytes 
in the endometrium. When implantation takes place, the number of leukocytes increases even further. Without 
implantation, the endometrial lining and its leukocytes are shed during menstruation7. Natural killer (NK) cells 
are abundantly present in the human endometrium8, 9. Endometrial NK cells increase in number during the men-
strual cycle, reaching a peak in the late secretory phase. If implantation occurs, endometrium will transform into 
decidua and the number of endometrial NK cells will increase even further and will make up 70% of the decid-
ual leukocytes during the first trimester. These uterine NK cells are different from NK cells found in peripheral 
blood. They are characterized as being CD56brightCD16−, while NK cells found in peripheral blood are mainly 
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CD56dimCD16+8, 10. Decidual NK cells produce specific cytokines and angiogenic factors to regulate invasion of 
fetal trophoblast cells and spiral artery remodeling7, 10.
Besides NK cells, also T cells are a major cell population in the endometrium and decidua8, 11. Decidual T 
cells differ from peripheral T cells by expression of activation markers such as CD45RO, CD69, HLA-DR, and 
CD2512, but their function and mechanism of fetus-specific immune recognition remains poorly defined13. It 
has long been thought that maternal tolerance towards fetal alloantigens was established by a predominance of 
T helper type 2 (Th2) immunity over Th1 immunity during pregnancy. However, this Th1/Th2 paradigm was 
found insufficient, since both Th1 and Th2 dominant immunity was observed in pregnancy complications14. 
Th17 cells produce IL-17 and mediate the induction of inflammation15. Higher levels of Th17 cells were found 
in women suffering from recurrent pregnancy loss and preterm delivery16–18. In contrast, mouse studies revealed 
that regulatory T cells (Treg) are essential for promoting immune tolerance towards the fetus, and activation of 
Treg is needed for pregnancy success, while depletion of Treg was associated with pregnancy failure19–22. Also, in 
humans, pregnancy complications, like recurrent pregnancy loss and preeclampsia, were found to be associated 
with lower numbers of Treg23–26. Altogether, this suggests that a tightly regulated balance between Th1, Th2, Th17, 
and Treg cells is required for successful pregnancy.
Although much effort has been put in elucidating how the immune system contributes to pregnancy, particu-
larly in mice, knowledge on human placentation is scarce. Especially little data is available on early implantation 
and placentation compared to term pregnancy decidual tissue. As local decidual immune regulation is paramount 
to successful pregnancy, immune phenotypic changes in the uterine immune environment that fit the notion of 
a well balanced Th1/Th2/Th17/Treg environment might be expected. In the present study, we made a detailed 
phenotypic and functional analysis of immune cells in both pre-implantation endometrium and in term decidua, 
with a focus on T cell subsets. We used menstrual blood as a source of endometrial cells because we showed 
previously, that with respect to cell composition and phenotypic characteristics, menstrual blood is very similar 
to biopsy-derived material27. The results of this study will provide us with a more profound insight into which 
adaptations of the uterine immune system during pregnancy are important for pregnancy success.
Results
The lymphocyte composition of term decidua differs from pre-pregnancy endome-
trium. Previously, comparisons between endometrium and decidua had to be inferred from separate studies 
since data on direct comparison of immune cell changes between endometrium and decidua are scarce. The 
recently designed method, whereby endometrial lymphocytes can be isolated from menstrual blood, allows for 
easier access to this material and opens up the opportunity to study pre-pregnancy endometrium together with 
decidual samples in the same set of experiments. Here, we directly compared the immune cell composition of 
menstrual blood (MMC), term decidua parietalis (DPMC), and peripheral blood (PBMC) mononuclear cells by 
using flow cytometric analysis (Fig. 1). Since cell yield from decidua basalis was too low for the extensive analysis 
we did here, maternal lymphocytes in the decidua parietalis are in close contact with chorionic trophoblast cells, 
and active immune regulation seems to place at the decidua parietalis as well28, 29, prompted our decision to opt 
for isolation of cells from decidua parietalis to study the fetal-maternal interface.
In accordance with previous studies, MMC and DPMC clearly differ from PBMC in percentages of lympho-
cytes, T cells, NK cells and NKT cells7–9, 27, 30, 31, and contained primarily CD56+CD16−NK cells, while the major-
ity of NK cells in PBMC were CD56+/−CD16+. In a direct comparison between MMC and DPMC, MMC revealed 
a higher percentage of NK cells (46.9% ± 16.4% and 24.3% ± 10.6% respectively). MMC (43.9% ± 15.10%) con-
tained a significant lower percentage of T cells, with an increased CD4+/CD8+ ratio, as compared to DPMC 
(67.1% ± 10.66%). In addition, MMC contained significantly less NKT cells (1.2% ± 0.9% versus 2.5% ± 1.1%) 
compared to DPMC. No significant difference in percentages of B cells between MMC and DPMC could be 
observed. Also, important to note is that MMC and DPMC derived lymphocytes are from mucosal origin since 
more CD69+ and CD103+, and less CD62L+ T and NK cells can be found compared to PBMC (Supplementary 
Fig. S2). After showing that MMC and DPMC clearly differ in immune cell composition, we investigated T cells 
in more depth for differences between pre-pregnancy endometrium and decidua.
Decidual T cells are more experienced than endometrial T cells. We next examined endometrial 
and decidual T cell subsets in more detail to know if the observed phenotype of more differentiated memory T 
cells in decidua compared to PBMC32 would also apply to endometrium. Compared to MMC derived T cells, 
DPMC derived T cells revealed a significantly lower percentage of CD45RA+ (53.4% ± 8.8% and 17.2% ± 7.4%, 
respectively) and a higher percentage of CD45RO+ cells (28.9% ± 8.0% and 66.4% ± 11.7% respectively) (Fig. 2b). 
In addition, we subdivided CD4+ and CD8+ T cells into naive T cells (CD45RA+CCR7+), effector T cells 
(Teff, CD45RA+CCR7−), effector memory T cells (EM, CD45RA−CCR7−), and central memory T cells (CM, 
CD45RA−CCR7+). Both CD4+ and CD8+ T cells present in DPMC were significantly less naive compared to 
MMC, while a significantly higher percentage of EM and CM T cells was present in DPMC (Fig. 2c). Thus, over 
the course of pregnancy, decidual T cells appear to acquire an experienced and differentiated phenotype.
To strengthen the claim that endometrial T cells are primed over the course of pregnancy and can differentiate 
towards a phenotype found in the decidua, we performed in vitro experiments whereby endometrial lympho-
cytes were stimulated with either rhIL-15 or anti-CD3/anti-CD28 mAb microbeads alone, or in combination. 
The rationale for using IL-15 is because IL-2 is hardly detected in decidua and after implantation, endometrial 
NK cells start to differentiate as a result of local IL-15 production9. After 5 days of culture, the distribution of T 
cell subsets was measured with flow cytometry in the same way as above. Endometrial T cells stimulated with 
anti-CD3/anti-CD28 mAb microbeads reveal a similar subset division as found in term decidual T cells, i.e. less 
naive T cells and more EM and CM T cells compared to control (medium) and day 0 (Supplementary Fig. S3). 
Whereas stimulation with IL-15 alone was not sufficient to lead to a similar differentiation, IL-15 did appear 
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 2884  | DOI:10.1038/s41598-017-03191-0
to have an effect on T cell differentiation when administered together with anti-CD3/anti-CD28 beads and as 
compared to the bead alone condition, i.e. more EM and less CM T cells. This may suggest that T cells need an 
additional TCR trigger before they can differentiate towards a more mature phenotype. These in vitro data showed 
that endometrial lymphocytes can be differentiated towards a phenotype reminiscent of term decidual T cells, 
which lends further support for the notion that over the course of pregnancy decidual T cells appear to acquire an 
experienced and differentiated phenotype.
The decidual immune environment is marked by a tolerance signature. The fetal-maternal inter-
face is the major site where maternal immune cells come into contact with cells of fetal origin. Treg are important 
for regulation of the decidual immune environment and pregnancy success19. DPMC contained significantly 
more CD4+CD25highCD127− Treg than MMC (9.5% ± 3.5% versus 5.2% ± 1.9%) (Fig. 3b). We further subdivided 
Treg based on expression of CD45RA and CD2533. DPMC contained significantly more CD4+CD25highCD45RA− 
activated and differentiated Treg than MMC (8.4% ± 5.9% versus 2.4% ± 1.6%), while the percentage of 
CD4+CD25+CD45RA+ naive Treg did not differ significantly (1.3% ± 1.2% versus 1.9% ± 1.3%) (Fig. 3c). Treg 
percentages in MMC did not differ from PBMC, but DPMC contained significantly less naive Treg compared to 
PBMC (1.3% ± 1.2% versus 3.4% ± 2.0%). This suggests, that different from the pre-implantation endometrium, 
the human decidual environment is marked by a immune signature that includes the activation and differentia-
tion of Treg.
Figure 1. Lymphocyte composition of peripheral blood, menstrual blood, and term decidua. Mononuclear cells 
were isolated from peripheral blood (PBMC, n = 17), menstrual blood (MMC, n = 17), and decidua parietalis 
(DPMC, n = 12). Percentages of lymphocytes (CD45+) based on side scatter (SS) and forward scatter (FS), T 
cells (CD56−CD3+; CD4+ and CD8+), NKT cells (CD3+CD56+), NK cells (CD3−CD56+; CD56+CD16+ and 
CD56+CD16−), and B cells (CD19+) were obtained by flow cytometric analysis. *P < 0.05, **P < 0.01, and 
***P < 0.001 (lines indicate mean, non-parametric Kruskal-Wallis with Dunns post-hoc test).
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Figure 2. CD4+ and CD8+ T cells subsets in peripheral blood (PBMC), menstrual blood (MMC) and term 
decidua parietalis (DPMC). (a) Representative staining for CD45RA and CD45RO on CD3+ T cells and 
CD45RA and CCR7 on CD4+ and CD8+ T cells from PBMC, MMC, and DPMC. (b) Expression of CD45RA 
and CD45RO on CD3+ T cells (PBMC n = 17, MMC n = 16, and DPMC n = 12. (c) CD4+ and CD8+ T cells are 
separated into four subsets based on the expression of CD45RA and CCR7. Naive T cell (CD45RA+CCR7+); 
effector T cell, Teff (CD45RA+CCR7−); effector memory T cell, EM (CD45RA−CCR7−); central memory T cell, 
CM (CD45RA−CCR7+) (PBMC n = 17, MMC n = 11, and DPMC n = 8). Lines indicate mean ± SD. *P < 0.05, 
**P < 0.01, and ***P < 0.001 (non-parametric Kruskal-Wallis with Dunns post-hoc test).
Figure 3. Distribution of regulatory T cells. (a) Representative staining of CD25, CD127, and CD45RA on 
CD4+ T cells from peripheral blood (PBMC, n = 17), menstrual blood (MMC, n = 16), and term decidua 
parietalis (DPMC, n = 12). (b) Percentage of CD25highCD127− Treg within CD4+ T cells in PBMC, MMC, and 
DPMC. (c) Distribution of naive Treg (CD45RA+CD25+) and differentiated Treg (CD45RA−CD25++) in CD4+ 
T cells. **P < 0.01, and ***P < 0.001 (lines indicate mean, non-parametric Kruskal-Wallis with Dunns post-
hoc test).
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 2884  | DOI:10.1038/s41598-017-03191-0
The Th1, Th2, and Th17 cell profile is similar between endometrium and term decidua. It is 
suggested that successful pregnancy requires a delicate Th1/Th2/Th17/Treg balance14. To investigate this balance, 
we classified CD4+ cells as Th1, nonconventional Th1 (Th1-like), Th2, or Th17 cells, based on the expression of 
the chemokine receptors CCR6, CXCR3, and CCR434. Blood Th1-like cells were reported to have a mixed Th1/
Th17 phenotype, i.e. production of RORC mRNA and IL-17, together with a higher production of TBX21 mRNA 
and IFN-γ than conventional Th1 cells, indicating higher Th1 activity34. Th cell composition of MMC and DPMC 
were both different from PBMC, with significantly less Th2, and more Th1 cells in the uterine environment 
(Fig. 4b). Between MMC and DPMC, percentages of Th1, Th2, Th17, and Th1-like cells did not differ significantly 
(Fig. 4b). When investigating the intracellular cytokine expression profile after PMA/Ionomycin/Brefeldin stimu-
lation, we observed a higher intrinsic capacity to express IFN-γ and IL-17 by DPMC CD4+ T cells (27.8% ± 15.4% 
and 4.4% ± 1.3% respectively) compared to CD4+ T cells from MMC (7.4% ± 3.3% and 2.6% ± 1.0% respectively), 
and also PBMC (7.5% ± 6.7% and 2.3% ± 1.3% respectively) (Fig. 4d).
In summary, a direct comparison between pre-pregnancy endometrium and term decidua reveals a activated 
immune signature, with more experienced conventional T cells and Treg. The distribution of Th subsets, defined 
by chemokine receptor expression patterns, did not differ significantly between endometrium and term decidua. 
However, the intrinsic capacity to produce IFN-γ and IL-17 was highest in term decidual CD4+ T cells, suggesting 
a possible role for both cytokines in the uterine environment during pregnancy.
Discussion
Local decidual immune regulation is paramount to successful pregnancy. Previous studies investigating the phe-
notype of immune cells in endometrium and decidua are fragmented, and limited to comparing immune cells 
in either endometrium or decidua with their counterparts in peripheral blood7–9, 27, 30, 31. Here, we performed a 
cross-sectional study, directly comparing the immune cell composition and functional capacity of pre-pregnancy 
endometrium and term decidua using flow cytometric analysis. We show clear differences in immune cell compo-
sition, suggestive of immune cell differentiation over the course of pregnancy, i.e. more experienced and less naive 
T cells and Treg in term decidua compared to pre-pregnancy endometrium. Analysis of the Th1/Th2/Th17/Treg 
subset composition showed that, while the distribution of Th1, Th2, and Th17 cells did not differ between term 
decidua and endometrium, there was a preference for Th1 over Th2 cells in the uterine environment compared 
to peripheral blood.
The role of T cells in pregnancy has been subject to various studies. T cells were shown to be a major cell pop-
ulation in both endometrium and decidua, but their function and antigen-specificity remains poorly defined13. 
We observed mainly effector memory (EM) and central memory (CM) T cells at the end of pregnancy, and they 
were thus more experienced and differentiated than T cells from pre-pregnancy endometrium. This suggests 
that over the course of pregnancy, T cells at the fetal-maternal interface may differentiate. After implantation of a 
blastocyst, endometrium will modify to decidua, and cells of fetal origin will come in to contact with lymphocytes 
at the maternal-fetal interface. This contact might differentiate endometrial T cells towards a phenotype as seen 
in decidual tissue, as suggested by our in vitro assay. The target specificity of the T cells and exact trigger for this 
differentiation is unclear, but multiple triggers have been suggested to play a role, including fetal alloantigens like 
major histocompatibility complex antigens (MHC) (HLA-C in humans)2, 4, 35, minor histocompatibility antigens 
(mHags)6, 36, and/or pathogen-derived antigens37. In accordance, Tilburgs et al. previously reported that in addi-
tion to the lower numbers of naive T cells in decidual tissue, mainly EM and few CM CD8+ T cells were present 
in term decidua32.
Pregnancy induces local enrichment of Treg at the fetal-maternal interface38, 39. These Treg play an important 
role in tolerance to the semi-allogeneic fetus and pregnancy in mice, since mouse studies showed that depletion 
of CD25+ Treg resulted in gestation failure in allogeneic pregnancies20–22. We showed that the percentage of 
CD4+CD25highCD127−Treg was higher in decidua than in endometrium, suggesting a more tolerogenic environ-
ment during pregnancy. As previously reported by our group27, no difference in the percentage of Treg in MMC 
and PBMC samples was observed. The increased percentage of Treg we found in term decidual tissue is compara-
ble to percentages found in other studies38. Based on the expression of CD45RA and CD25, human CD4+ T cells 
can be separated into differentiated Treg and naive Treg33. We showed that term decidua contained more differen-
tiated Treg than endometrium, while the presence of naive Treg was lower. In peripheral blood, these differenti-
ated Treg were shown to be derived from recently activated naive Treg and were suggested to be the main effectors 
of suppression33. In mice, it was shown that during the course of pregnancy Treg will acquire a protective regula-
tory memory phenotype to fetal antigen. These memory Treg persist after pregnancy and re-accumulate rapidly 
in a subsequent pregnancy40. A similar phenomenon thus may take place in the uterus during human pregnancy.
Not only Treg, but the overall balance between Th1, Th2, Th17, and Treg cells is suggested to be of relevance 
for successful pregnancy14. Th subsets can be classified by the production of particular cytokines by T cells, or by 
the expression of different chemokine receptors on T cells34. Using a classification based on chemokine receptor 
expression patterns, we found that both term decidua and pre-pregnancy endometrium held relatively more Th1 
cells, and less Th2 cells compared to peripheral blood. Our results thus showed that in the uterine environment, 
there is a preference of Th1 over Th2 cells. The same trend was also seen in first trimester decidua41. This suggests 
that this preference is already present in pre-pregnancy endometrium and stays over the course of pregnancy 
until term. Between term decidua and endometrium, the distribution of Th1, Th2, Th17, and Th1-like cells did 
not significantly differ. The similar Th cell distribution between endometrium and term decidua suggests that 
the pre-pregnancy endometrium might already be prepared for pregnancy. It can therefore be envisaged that 
women who experience recurrent miscarriages already have an imbalance in their endometrium affecting a suc-
cessful pregnancy outcome. For instance, Shimada et al.42 showed that in the endometrium of women with recur-
rent miscarriages less CD4+IFN-γ+ T cells were present. In-depth analysis of the Th1/Th2/Th17/Treg balance 
in the endometrium of women with fertility issues might give us more insight into the underlying pathogenesis 
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Figure 4. Distribution of CD4+ Th cell subsets in peripheral blood (PBMC), menstrual blood (MMC), and 
term decidua parietalis (DPMC) and production of IFN-γ and IL-17 by CD4+ T cells. (a,c) Representative 
gating for CCR6, CXCR3, and CCR4 on CD4+ T cells and for IFN-γ and IL-17 by CD4+ T cells from PBMC, 
MMC, and DPMC. (b) Th1, Th2, Th17, and nonconventional Th1 (Th1-like) CD4+ T cells can be classified 
based on the expression of CCR6, CXCR3, and CCR434. CCR6−CXCR3+CCR4−, Th1; CCR6+CXCR3+CCR4−, 
Th1-like; CCR6−CXCR3−CCR4+, Th2; CCR6+CXCR3−CCR4+, Th17 (PBMC n = 17, MMC n = 11, DPMC 
n = 7). (d) Production of IFN-γ and IL-17 by CD4+ T cells from PBMC (n = 12), MMC (n = 15), and DPMC 
(n = 7). *P < 0.05, **P < 0.01, and ***P < 0.001 (lines indicate mean, non-parametric Kruskal-Wallis with 
Dunns post-hoc test).
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of pregnancy complications and could potentially predict subsequent pregnancy outcome. Interestingly, when 
looking at the actual intrinsic capacity of CD4+ T cells to express IL-17 and IFN-γ intracellular, we found more 
expression of IFN-γ and IL-17 by decidual T cells compared to peripheral and endometrial CD4+ T cells. In first 
trimester decidua, the percentage of IL-17+ T cells was also found to be higher compared to peripheral blood16, 
43, while the expression of IFN-γ was lower44. Although IFN-γ and IL-17 have been related to pregnancy com-
plications, and an excess of inflammation was associated with a negative impact on pregnancy outcome16, 18, 43, 
45, 46, the presence of IFN-γ+ and IL-17+ T cells in healthy term decidua suggests that these cytokines may play 
an important role during pregnancy. IFN-γ for instance, was shown to be essential for implantation, decidual 
integrity and placental growth in mice45, 47. IL-17 plays an important role in host defense against pathogens15, but 
it was also shown that IL-17 increases the production of progesterone by JEG-3 cells and supports the survival, 
proliferation and invasive capacity of trophoblast cells48–50. The presence of normal, balanced levels of IFN-γ and 
IL-17 could play a role during placentation and/or prevention of intrauterine infection, but this is still far from 
understood. While we did not show a difference in the capacity of peripheral and endometrial CD4+ T cell to 
express IL-17, Hosseini et al.51 showed more IL-17+CD3+ T cells in menstrual blood compared to peripheral 
blood. This difference can be explained by a different gating approach since we looked at percentage of CD4+ 
T cells, while they looked at CD3+ T cells. When we would gate our data in a similar way, we found a similar, 
although not significant, difference between peripheral and menstrual blood. This can be explained by the higher 
percentages in our peripheral blood samples (average 4.5%) compared to theirs (average 0.9%). Several reasons 
could explain this discrepancy: duration of stimulation (4 h vs 6 h) or differences in stimulus and/or concentration 
used (PMA (12.5 ng/ml)/Ionomycin (500 ng/ml)/Brefeldin A (5 µg/ml) by us versus PMA (25 ng/ml)/Ionomycin 
(500 ng/ml)/Monensin (1 µM/ml) by them).
A limitation or our study is that we were not able to study decidual tissue at several time-points during preg-
nancy, to actually show the changes that occur with time. We could only infer this from the data collected from 
pre-pregnancy endometrium (implantation stage) and term decidua.
In conclusion, we showed that the immune cell composition of pre-pregnancy endometrium differs from 
term decidua, but with a similar distribution of Th1, Th2, and Th17 cells. At the end of pregnancy, the uterine 
immune environment appears to be marked by a tolerogenic phenotype with more experienced T cells and Treg 
with a potential beneficial phenotype. How exactly the phenotype of the uterine immune cells is shaped and how 
this differentiation is maintained is unclear. Therefore, in follow-up studies, we aim to explore the influence of 
different immune triggers on immune cells in the uterine environment before and during pregnancy. This may 
add insight to our understanding of the pathogenesis of pregnancy complications.
Materials and Methods
Blood and tissue sampling. Paired peripheral blood and menstrual blood was collected from 17 healthy 
women with regular menstrual cycles. Hormones can modulate immune cell responses and change the nat-
ural menstrual cycle52, 53. To avoid any artificial effect on the hormonal balance, none of the menstrual blood 
donors used any hormonal contraceptives like birth control pill or an intra-uterine device. See Supplementary 
Table S1 for donor characteristics. 10 ml of peripheral blood was collected in ACD-A tubes. Menstrual blood 
was collected during the first 36 hours of menstruation using a menstrual cup (Femmecup Ltd, London, UK). 
Every 12 hours, the sample was decanted from the cup in a 30 ml tube containing 8 ml 10% human pooled 
serum (HPS) medium [RPMI 1640 medium supplemented with pyruvate (1 mM), glutamax (2 mM), penicillin 
(100 U/ml), streptomycin (100 mg/ml) (Thermo Fisher Scientific, Waltham, USA), 10% HPS (manufactured 
in-house), and 0.3% sodium citrate (Merck, Darmstadt, Germany)] and stored at room temperature. After 
1.5 days, three tubes containing different fractions of menstrual blood were processed immediately to assess 
lymphocyte composition. Decidua parietalis, the maternal side of the fetal-maternal interface, was obtained 
from 19 healthy women after uncomplicated term pregnancy. Decidual samples were obtained after delivery 
by planned elective cesarean section and processed immediately. The study was approved by the institutional 
review board (Commissie Mensgebonden Onderzoek region Arnhem-Nijmegen, CMO nr. 2009/004) and was 
performed in accordance with the relevant guidelines and regulations. Samples were obtained from each par-
ticipant upon written informed consent.
Isolation of lymphocytes. One ml of peripheral blood was lysed with 25 ml lysis buffer [NH4CL + KHCO3/
Na4EDTA (Merck, Darmstadt, Germany) diluted in H2O (Versol, Lyon, France)] for 10 min and washed 3x times 
with PBS (Braun, Melsungen, Germany). These cells were used for surface staining. For intracellular stain-
ing, peripheral blood mononuclear cells (PBMC) were isolated by means of density gradient centrifugation 
(Lymphoprep; Axis-Shield PoC AS, Oslo, Norway). After isolation, cells were washed twice with PBS. Menstrual 
blood was washed with PBS and passed through a 70 µm cell strainer (Falcon, Durham, USA) to remove clots 
and mucus. Granulocytes were depleted by use of a granulocyte depletion kit according to the manufacturer’s 
instructions (STEMCELL Technologies, Vancouver, Canada). After isolation, cells were washed twice with 
PBS containing 2% HPS. Decidua parietalis was collected as described previously38. Briefly, after removing the 
amnion, the decidua parietalis was carefully scraped from the chorion. The obtained tissue was washed thor-
oughly in PBS before mincing with scissors. The resulting pulp was washed again until the supernatant became 
transparent. The tissue was enzymatically incubated with 1% collagenase I (Gibco Life Technologies, Waltham, 
USA) and 1% DNAse (Roche Diagnostics, Risch-Rotkreuz, Switzerland) in a water bath at 37 °C while shaking 
for 60 minutes. After washing with RPMI medium, the suspension was passed through a 70 μm cell strainer 
(Greiner, Frickenhausen, Germany) and washed again with RPMI. Lymphocytes were obtained after density gra-
dient centrifugation (Lymphoprep). Analysis was done immediately on fresh material to exclude the influence of 
cryopreservation on the expression of certain markers. For optimal analysis of the chemokine receptors CD183 
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(CXCR3), CD194 (CCR4), and CD196 (CCR6) on decidual cells, cells were put to rest at 37 °C in a humidified 
5% CO2 incubator for 16 hours before staining for flow cytometry. Typically 93%, 95%, and 81% of respectively 
peripheral, menstrual, and decidual lymphocytes were viable cells (Supplementary Fig. S1).
Flow cytometry. Samples were phenotypically analyzed using the 10-color NaviosTM flow cytometer 
(Beckman Coulter, Fullerton, CA, USA). Briefly, cells were washed twice with PBS + 0.2% bovine serum albumin 
(BSA; Sigma-Aldrich, St. Louis, USA) and labeled for 20 min at RT in the dark with the fluorochrome-conjugated 
mAbs of interest. Samples were washed twice with PBS + 0.2% BSA. For cell surface staining of B cells, mono-
cytes/macrophages, T cells, Treg, NKT cells and NK cells, the following conjugated mAbs were used: CD3-PE/
ECD/PB (Beckman Coulter; UCHT1), CD4-PC5.5/PB (Beckman Coulter; 13B8.2), CD4-AF700 (eBioscience, 
San Diego, USA; RPA-T4), CD8-APC-AF700/APC-AF750 (Beckman Coulter; B9.11), CD14-ECD (Beckman 
Coulter; RMO52), CD16−FITC (Beckman Coulter; 3G8), CD19-APC-AF750 (Beckman Coulter; J3-119), 
CD25-PC7/APC (BD Biosciences, New Jersey, USA; M-A251 and 2A3), CD45-KO (Beckman Coulter; J33), 
CD45RA-FITC/ECD (Beckman Coulter; ALB11 and 2H4LDH11LDB9), CD45RO-ECD (Beckman Coulter; 
UCHL1), CD56-APC (Beckman Coulter; N901), CD62L-FITC/ECD (eBiosience and Beckman Coulter; DREG-
56), CD69-PE (Beckman Coulter; TP1.55.3), CD103-FITC (eBioscience; B-Ly7), CD127-APC-AF700 (Beckman 
Coulter; R34.34), CD183-PC5.5 (CXCR3; Biolegend, San Diego, USA; G025H7), CD194-PC7 (CXCR4; BD 
Biosciences; 1G1), CD196-PE (CCR6; BD Biosciences; 11A9), CD197-BV421 (CCR7; BioLegend; G043H7), and 
Fixable Viability Dye-eFluor780 (eBioscience). For intracellular staining, samples were permeabilized and fixed 
according to manufacturer’s instructions (eBioscience). Cells were incubated with the conjugated mAbs of inter-
est for 30 min at 4 °C in the dark. The following conjugated mAbs for intracellular staining were used: IFN-γ-PC7 
(4 S.B3) and IL-17-APC-AF780 (eBioscience; eBio64DEC17). A minimum of 200.000 cells per staining was 
applied. Fluorescence minus one (FMO) and isotype controls were used for gate settings. The data were analyzed 
using Kaluza V1.1 software (Beckman Coulter). A typical gating strategy used for analysis of T cells and NK cells 
is depicted in Supplementary Fig. S1.
Functional analysis. Peripheral blood (PBMC), menstrual blood (MMC), and decidua parietalis (DPMC) 
mononuclear cells were stimulated with phorbol-12-myristate-13-acetate (PMA), ionomycin and brefeldin A 
(respectively, 12.5 ng/ml, 500 ng/ml and 5 µg/ml; Sigma-Aldrich, St. Louis, USA) for 4 hours at 37 °C in a humid-
ified 5% CO2 incubator. Functionality was determined by measuring the intracellular production of IFN-γ and 
IL-17 by flow cytometry as described above.
Differentiation assay. MMC were stimulated in vitro with medium as a control, with anti-CD3/anti-CD28 
mAb-coated microbeads in a 1:10 bead-to-cell ratio (Invitrogen, Bleiswijk, The Netherlands) alone, rhIL-15 
(100 ng/ml; Gibco Life Technologies) alone, and beads together with rhIL-15 in 96-well U-bottom plates. The 
rationale for using IL-15 is because IL-2 is hardly detected in decidua and after implantation, endometrial NK 
cells start to differentiate as a result of local IL-15 production9. After 5 days of culture at 37 °C in a humidified 5% 
CO2 incubator, cells were harvested and the presence of T cell subsets and differentiation was measured with flow 
cytometry.
Statistical analysis. Statistical analyses were performed using GraphPad Prism 5 (Graphpad software Inc., 
La Jolla, CA, USA). Non-parametric Kruskal-Wallis with Dunns post-hoc test was performed to compare PBMC, 
MMC, and DPMC samples. Statistical significance was denoted as values of P < 0.05. All indicated values are 
mean percentages ± SD.
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